| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2022 | Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort | YC Hsu; DW Jun; CY Peng; ML Yeh; H Trinh; GL Wong; SE Kim; CH Chen; H Oh; CH Lin; L Trinh; VW Wong; E Yoon; SB Ahn; D Huang; YK Cho; JY Jeong; SW Jeong; HS Kim; Q Xiw; L Liu; M Riveiro-Barciela; PC Tsai; EV Accarino; H Toyoda; M Enomoto; C Preda; S Marciano; J Hoang; CF Huang; R Kozuka; S Yasuda; D Istratescu; DH Lee; JY Su; YT Huang ; JF Huang; CY Dai; WL Chuang; MF Yuen; A Gadano; R Cheung; SG Lim; M Buti; ML Yu; MH Nguyen | HEPATOLOGY INTERNATIONAL 16, 1297-1307 | |||
| 2022 | Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation | YC Hsu; V Suri; MH Nguyen; YT Huang ; CY Chen; IW Chen; CH Tseng; CY Wu; JT Lin; D Pan; A Gaggar; Ondrej Podlaha | Gastroenterology 162(4), 1160-1170.e1 | |||
| 2019 | Mac-2-Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients with Chronic Hepatitis B or C Infection | T Jun; YC Hsu; S Ogawa; YT Huang ; ML Yeh; CH Tseng; CF Huang; CM Tai; CY Dai; JF Huang; WL Chuang; ML Yu; Y Tanaka; MH Nguyen | Hepatology Communication 3(4), 493-503 | |||
| 2018 | Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B | YC Hsu; T Jun; YT Huang ; ML Yeh; CL Lee; SH Cho; JT Lin; ML Yu; MH Nguyen; Y Tanaka | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48(10), 1128-1137 |
